HCG Found in WHO Tetanus Vaccine in Kenya Raises Concern in the Developing World

File attachments: 
Average: 10 (1 vote)

John W. Oller Jr.1, Christopher A. Shaw2,3, Lucija Tomljenovic2,3, Stephen K. Karanja4, Wahome Ngare4, Felicia M. Clement5, Jamie Ryan Pillette5

1Communicative Disorders, University of Louisiana, Lafayette, USA
2Ophthalmology and Visual Sciences, Graduate Program in Experimental Medicine, University of British Columbia, Vancouver, Canada
3Neural Dynamics Research Group, Vancouver, Canada
4Kenya Catholic Doctors Association, Nairobi, Kenya
5University of Louisiana, Lafayette, USA


In 1993, WHO announced a “birth-control vaccine” for “family planning”. Published research shows that by 1976 WHO researchers had conjugated te- tanus toxoid (TT) with human chorionic gonadotropin (hCG) producing a “birth-control” vaccine. Conjugating TT with hCG causes pregnancy hor- mones to be attacked by the immune system. Expected results are abortions in females already pregnant and/or infertility in recipients not yet impregnated. Repeated inoculations prolong infertility. Currently WHO researchers are working on more potent anti-fertility vaccines using recombinant DNA. WHO publications show a long-range purpose to reduce population growth in unstable “less developed countries”. By November 1993 Catholic publica- tions appeared saying an abortifacient vaccine was being used as a tetanus prophylactic. In November 2014, the Catholic Church asserted that such a program was underway in Kenya. Three independent Nairobi accredited bio- chemistry laboratories tested samples from vials of the WHO tetanus vaccine being used in March 2014 and found hCG where none should be present. In October 2014, 6 additional vials were obtained by Catholic doctors and were tested in 6 accredited laboratories. Again, hCG was found in half the samples. Subsequently, Nairobi’s AgriQ Quest laboratory, in two sets of analyses, again found hCG in the same vaccine vials that tested positive earlier but found no hCG in 52 samples alleged by the WHO to be vials of the vaccine used in the Kenya campaign 40 with the same identifying batch numbers as the vials that tested positive for hCG. Given that hCG was found in at least half the WHO vaccine samples known by the doctors involved in administering the vaccines

How to cite this paper: Oller Jr., J.W., Shaw, C.A., Tomljenovic, L., Karanja, S.K., Ngare, W., Clement, F.M. and Pillette, J.R. (2017) HCG Found in WHO Tetanus Vac- cine in Kenya Raises Concern in the De- veloping World. Open Access Library Jour- nal, 4: e3937. https://doi.org/10.4236/oalib.1103937

Received: September 12, 2017 Accepted: October 24, 2017 Published: October 27, 2017

Copyright © 2017 by authors and Open Access Library Inc.
This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).

Open Access

DOI: 10.4236/oalib.1103937

Oct. 27, 2017 1 Open Access Library Journal

J. W. Oller Jr. et al.

to have been used in Kenya, our opinion is that the Kenya “anti-tetanus” campaign was reasonably called into question by the Kenya Catholic Doctors Association as a front for population growth reduction